The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) closed at $7.12 in the last session, down -7.53% from day before closing price of $7.70. In other words, the price has decreased by -$7.53 from its previous closing price. On the day, 1.02 million shares were traded. DNA stock price reached its highest trading level at $7.7704 during the session, while it also had its lowest trading level at $7.1.
Ratios:
We take a closer look at DNA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.62 and its Current Ratio is at 5.62. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.61.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when Che Austin bought 99 shares for $7.75 per share.
Che Austin bought 99 shares of DNA for $745 on Mar 24 ’25. On Mar 21 ’25, another insider, Che Austin, who serves as the Officer of the company, bought 99 shares for $7.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 413199232 and an Enterprise Value of 293269376. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.82 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at 1.292 whereas that against EBITDA is -0.705.
Stock Price History:
The Beta on a monthly basis for DNA is 1.22, which has changed by -0.83818185 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, DNA has reached a high of $48.00, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is -31.63%, while the 200-Day Moving Average is calculated to be -30.48%.
Shares Statistics:
According to the various share statistics, DNA traded on average about 1.66M shares per day over the past 3-months and 1201820 shares per day over the past 10 days. A total of 42.70M shares are outstanding, with a floating share count of 36.98M. Insiders hold about 32.80% of the company’s shares, while institutions hold 57.91% stake in the company. Shares short for DNA as of 1741910400 were 9976616 with a Short Ratio of 5.46, compared to 1739491200 on 8753300. Therefore, it implies a Short% of Shares Outstanding of 9976616 and a Short% of Float of 29.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
